SI9011006B - Novi 8-substituirani-2-aminotetralini - Google Patents

Novi 8-substituirani-2-aminotetralini Download PDF

Info

Publication number
SI9011006B
SI9011006B SI9011006A SI9011006A SI9011006B SI 9011006 B SI9011006 B SI 9011006B SI 9011006 A SI9011006 A SI 9011006A SI 9011006 A SI9011006 A SI 9011006A SI 9011006 B SI9011006 B SI 9011006B
Authority
SI
Slovenia
Prior art keywords
formula
alkyl
compound
aryl
hydrogen
Prior art date
Application number
SI9011006A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9011006A (en
Inventor
Nils-Erik Anden
Hoeoek Berit Christina Elisabet Backlund
Anna Lena Maria Bjoerk
Uli Alf Hacksell
Sven-Erik Hillver
Ye Liu
Eva Charlotta Mellin
Eva Marie Persson
Karl Jerk Vallgarda
Hong Yu
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of SI9011006A publication Critical patent/SI9011006A/sl
Publication of SI9011006B publication Critical patent/SI9011006B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
SI9011006A 1989-05-26 1990-05-23 Novi 8-substituirani-2-aminotetralini SI9011006B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8901889A SE8901889D0 (sv) 1989-05-26 1989-05-26 Novel 8-substituted-2-aminotetralines
YU100690A YU48830B (sh) 1989-05-26 1990-05-23 Novi 8-supstituisani-2-aminotetralini

Publications (2)

Publication Number Publication Date
SI9011006A SI9011006A (en) 1997-12-31
SI9011006B true SI9011006B (sl) 1998-12-31

Family

ID=20376074

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9011006A SI9011006B (sl) 1989-05-26 1990-05-23 Novi 8-substituirani-2-aminotetralini

Country Status (41)

Country Link
US (1) US5635537A (pt)
EP (1) EP0399982B1 (pt)
JP (1) JP2818692B2 (pt)
KR (1) KR100193981B1 (pt)
CN (1) CN1023399C (pt)
AT (1) ATE129696T1 (pt)
AU (1) AU644081B2 (pt)
CA (1) CA2032498C (pt)
CY (1) CY1989A (pt)
CZ (1) CZ286038B6 (pt)
DD (1) DD298909A5 (pt)
DE (1) DE69023274T2 (pt)
DK (1) DK0399982T3 (pt)
DZ (1) DZ1417A1 (pt)
ES (1) ES2078962T3 (pt)
FI (1) FI114151B (pt)
GR (1) GR3018566T3 (pt)
HK (1) HK55697A (pt)
HR (1) HRP920622B1 (pt)
HU (2) HUT58685A (pt)
IE (1) IE75057B1 (pt)
IL (1) IL94428A (pt)
IS (1) IS1663B (pt)
JO (1) JO1617B1 (pt)
LT (1) LT3966B (pt)
LV (2) LV10243B (pt)
MX (1) MX20842A (pt)
NO (1) NO176603C (pt)
NZ (1) NZ233724A (pt)
PH (1) PH31110A (pt)
PL (2) PL165166B1 (pt)
PT (1) PT94163B (pt)
RU (1) RU2093507C1 (pt)
SA (1) SA90100274B1 (pt)
SE (1) SE8901889D0 (pt)
SI (1) SI9011006B (pt)
SK (1) SK256090A3 (pt)
UA (1) UA40562C2 (pt)
WO (1) WO1990014330A1 (pt)
YU (1) YU48830B (pt)
ZA (1) ZA903801B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2051399C (en) * 1989-05-31 2003-12-30 Chiu-Hong Lin Therapeutically useful 2-aminotetralin derivatives
CA2048846A1 (en) * 1990-08-15 1992-02-16 Craig Steven Hoechstetter Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ241495A (en) * 1991-02-08 1994-10-26 Lilly Co Eli 2-amino-1,2,3,4-tetrahydronaphthalene and 3-aminochromane derivative, preparation and pharmaceutical compositions thereof
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5627199A (en) * 1991-03-28 1997-05-06 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz [CD] indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
AU1106195A (en) * 1994-11-09 1996-06-06 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
GB9509156D0 (en) 1995-05-05 1995-06-28 Sandoz Ltd Organic compounds
WO2007081542A2 (en) 2006-01-06 2007-07-19 Sepracor Inc. Tetralone-based monoamine reuptake inhibitors
CA3208011A1 (en) 2021-03-17 2022-09-22 Sarah Harris Methods of treating atopic dermatitis with anti il-13 antibodies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4247907A (en) * 1978-11-27 1981-01-27 International Business Machines Corporation Method and apparatus for typing characters and optically readable binary representations thereof on same page
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
DE3479314D1 (en) * 1984-05-22 1989-09-14 Nelson Res & Dev Substituted 2-aminotetralins and processes for synthesis
DE3660959D1 (de) * 1985-06-26 1988-11-24 Smithkline Beckman Corp Benz-trisubstituted 2-aminotetralins
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
CA2026775C (en) * 1989-01-09 1998-04-07 Per Arvid Emil Carlsson Halo substituted aminotetralins
CA2051399C (en) * 1989-05-31 2003-12-30 Chiu-Hong Lin Therapeutically useful 2-aminotetralin derivatives

Also Published As

Publication number Publication date
NO176603C (no) 1995-05-03
IL94428A (en) 1995-12-31
RU2093507C1 (ru) 1997-10-20
LV11736A (lv) 1997-04-20
ES2078962T3 (es) 1996-01-01
CZ286038B6 (cs) 1999-12-15
DZ1417A1 (fr) 2004-09-13
SE8901889D0 (sv) 1989-05-26
NO176603B (no) 1995-01-23
IS1663B (is) 1997-07-04
LV10243B (en) 1995-04-20
DE69023274T2 (de) 1996-04-11
AU644081B2 (en) 1993-12-02
PL285330A1 (en) 1991-11-04
CA2032498C (en) 2002-03-26
FI114151B (fi) 2004-08-31
EP0399982A1 (en) 1990-11-28
IE901833L (en) 1990-11-26
FI910381A0 (fi) 1991-01-25
IE75057B1 (en) 1997-08-27
MX20842A (es) 1993-11-01
LTIP1723A (en) 1995-08-25
YU48830B (sh) 2002-03-18
IS3580A7 (is) 1990-11-27
PT94163A (pt) 1991-01-08
JPH04500362A (ja) 1992-01-23
SA90100274B1 (ar) 2005-06-01
CN1047494A (zh) 1990-12-05
KR100193981B1 (ko) 1999-06-15
LV10243A (lv) 1994-10-20
HRP920622A2 (en) 1998-06-30
CA2032498A1 (en) 1990-11-27
CN1023399C (zh) 1994-01-05
LV11736B (en) 1997-10-20
LT3966B (en) 1996-05-27
AU5818590A (en) 1990-12-18
WO1990014330A1 (en) 1990-11-29
US5635537A (en) 1997-06-03
CY1989A (en) 1997-09-05
HU904810D0 (en) 1991-06-28
EP0399982B1 (en) 1995-11-02
ZA903801B (en) 1991-01-30
PT94163B (pt) 1996-12-31
HK55697A (en) 1997-05-09
SI9011006A (en) 1997-12-31
SK280731B6 (sk) 2000-07-11
HRP920622B1 (en) 2000-04-30
DD298909A5 (de) 1992-03-19
KR920701121A (ko) 1992-08-11
HU211880A9 (en) 1995-12-28
HUT58685A (en) 1992-03-30
SK256090A3 (en) 2000-07-11
JP2818692B2 (ja) 1998-10-30
PH31110A (en) 1998-02-23
PL164245B1 (pl) 1994-07-29
CZ256090A3 (cs) 1999-10-13
NO910310D0 (no) 1991-01-25
IL94428A0 (en) 1991-03-10
JO1617B1 (en) 1991-11-27
NO910310L (no) 1991-01-25
GR3018566T3 (en) 1996-03-31
DE69023274D1 (de) 1995-12-07
YU100690A (en) 1992-05-28
PL165166B1 (pl) 1994-11-30
NZ233724A (en) 1993-01-27
DK0399982T3 (da) 1996-03-04
ATE129696T1 (de) 1995-11-15
UA40562C2 (uk) 2001-08-15

Similar Documents

Publication Publication Date Title
SI9011006B (sl) Novi 8-substituirani-2-aminotetralini
KR920701193A (ko) 신규 크로만 및 티오크로만 유도체
FR2582309A1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
HUP9800781A2 (hu) Propanol-amin-származékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények, valamint ezek alkalmazása
JPS6110583A (ja) ピラゾ−ル環がアルキル化されたピラゾロキノリン類およびその製造中間体
RS49711B (sr) Postupak za dobijanje 1,4- dihidropiridina i jedinjenja koja se primenjuju u tom postupku
Campaigne et al. Synthesis of β-Dimethylaminoethyl and α-Hydroxy-β-Dimethylaminoethyl Derivatives from Organolithium Compounds and Tetramethyoxamide
SK158195A3 (en) Application of 5-acyl-1,4-dihydropyridines, 5-acyl- -1,4-dihydropyridines, manufacturing process thereof and pharmaceutical compositions containing them
Kriis et al. Asymmetric synthesis of 2, 3, 4-trisubstituted piperidines
NZ511157A (en) Derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol
Hathaway et al. A new, potent, conformationally-restricted analog of amphetamine: 2-amino-1, 2-dihydronaphthalene
KR101057304B1 (ko) 키랄 촉매를 이용한 아스파르트산 유도체의 제조방법
Hasegawa et al. Development of new chiral auxiliary derived from (S)-(-)-phenylethylamine for a synthesis of enantiopure (R)-2-propyloctanoic acid
WO2023054626A1 (ja) シクロプロパンアミド誘導体
SK67295A3 (en) Phenylethylamine and phenylpropylamine, manufacturing process thereof and pharmaceutical composition containing them
HU176277B (en) Process for producing cycloalkyl-amine derivatives
Iqbal et al. Enantioselective syntheses and calcium channel modulating effects of (+)‐and (−)‐3‐isopropyl 5‐(4‐methylphenethyl) 1, 4‐dihydro‐2, 6‐dimethyl‐4‐(2‐pyridyl)‐3, 5‐pyridinedicarboxylates
EA200000527A3 (ru) Новые бициклические амино-пиразиноновые соединения, способ их получения и фармацевтические композиции, содержащие их
TH8849A (th) 8-ซับสทิทิวเทด-2-อะมิโนเททระลีนชนิดใหม่
OTOMASU et al. Synthesis of Condensed Quinoxalines. II. A New Synthesis of Pyrrolo-[2, 3-b] quinoxalines
Vyzir et al. Synthesis of Cyclopropyl-and Cyclobutylpiperidines: Advanced Building Blocks for Drug Discovery
EP1204636A1 (en) 3-oxopropane-1-sulphonic acids and sulphonates
TH21386B (th) 8-ซับสทิทิวเทด-2-อะมิโนเททระลีนชนิดใหม่
US3437689A (en) Aromatic amino acid
JP2006524695A (ja) ２個の隣接するキラル中心を有する環化合物を調製する方法

Legal Events

Date Code Title Description
IF Valid on the event date